▲ Peaking
Business
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
1 news trends Newsylist has tracked involving Drop Eczema Drug Amid Review of Pipeline Under New CEO — newest first.
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.